Your browser doesn't support javascript.
loading
Ultrasound-Based Grading System for Radiation-Induced Acute Breast Toxicity.
Wang, Jing; Zhou, Boran; Yang, Xiaofeng; Tridandapani, Srini; Lin, Jolinta; Torres, Mylin A; Liu, Tian.
Afiliação
  • Wang J; Department of Radiation Oncology, Emory University, Atlanta, Georgia, USA.
  • Zhou B; Department of Radiation Oncology, Emory University, Atlanta, Georgia, USA.
  • Yang X; Department of Radiation Oncology, Emory University, Atlanta, Georgia, USA.
  • Tridandapani S; Department of Radiology, University of Alabama, Birmingham, Alabama, USA.
  • Lin J; Department of Radiation Oncology, Emory University, Atlanta, Georgia, USA.
  • Torres MA; Department of Radiation Oncology, Emory University, Atlanta, Georgia, USA.
  • Liu T; Department of Radiation Oncology, Emory University, Atlanta, Georgia, USA.
J Ultrasound Med ; 42(6): 1307-1317, 2023 Jun.
Article em En | MEDLINE | ID: mdl-36583524
ABSTRACT

OBJECTIVES:

To introduce an ultrasound-based scoring system for radiation-induced breast toxicity and test its reliability.

METHODS:

Breast ultrasound (BUS) was performed on 32 patients receiving breast radiotherapy (RT) to assess the radiation-induced acute toxicity. For each patient, both the untreated and irradiated breasts were scanned at five locations 1200, 300, 600, 900, and tumor bed to evaluate for heterogenous responses to radiation within the entire breast. In total, 314 images were analyzed. Based on ultrasound findings such as skin thickening, dermis boundary irregularity, and subcutaneous edema, a 4-level, Likert-like grading scheme is proposed none (G0), mild (G1), moderate (G2), and severe (G3) toxicity. Two ultrasound experts graded the severity of breast toxicity independently and reported the inter- and intra-observer reliability of the grading system. Imaging findings were compared with standard clinical toxicity assessments using Common Terminology Criteria for Adverse Events (CTCAE).

RESULTS:

The inter-observer Pearson correlation coefficient (PCC) was 0.87 (95% CI 0.83-0.90, P < .001). For intra-observer repeatability, the PCC of the repeated scores was 0.83 (95% CI 0.78-0.87, P < .001). Imaging findings were compared with standard clinical toxicity assessments using CTCAE scales. The PCC between BUS scores and CTCAE results was 0.62 (95% CI 0.35-0.80, P < .001). Among all locations, 600 and tumor bed showed significantly greater toxicity compared with 1200 (P = .04).

CONCLUSIONS:

BUS can investigate the cutaneous and subcutaneous tissue changes after RT. This BUS-based grading system can complement subjective clinical assessments of radiation-induced breast toxicity with cutaneous and subcutaneous sonographic information.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lesões por Radiação / Neoplasias da Mama / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lesões por Radiação / Neoplasias da Mama / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article